Oxford Biosystems
  • News

    News from Oxford BioSystems

    News from Oxford BioSystems
26Jul

Oxford BioSystems announces exclusive contract with Tecan UK

Oxford Biosystems | 26 Jul, 2023 | General | Return|

Oxford BioSystems is pleased to announce our exclusive contract with Tecan UK to supply the IBL product range in the UK and Republic of Ireland.

This agreement is effective from July 2023 and we are looking forward to working with new and existing customers to introduce a variety of exciting products from IBL.

For more information, please see the attached letter. Information about the IBL products can also be found on the Tecan IBL website.

Please do not hesitate to contact us if you have any questions or would like to arrange a meeting with one of our Account Managers.

About the Author

Related

The Value of soluble Interleukin-2 Receptor (sIl-2R) as a Diagnostic and Predictive Biomarker

The interleukin-2 receptor (IL-2R), also known as CD25, is a transmembrane protein, which is up-regu...

Read More >

Manage Human MxA Protein

Human MxA protein (Myxovirus resistance protein 1), the product of the MX1 gene, is a 76-kDa protein...

Read More >

Q-View™ Imager Plus: High-Resolution Imaging for Multiplex ELISAs

As laboratories strive to produce faster, more consistent and publication-quality immunoassay data, ...

Read More >

Urinary Antigen Testing

Pneumonia is a common illness affecting approximately 450 million people a year and occurring in all...

Read More >

Urinary Antigens and Community-Acquired Pneumonia

Rapid automated testing for Urinary Antigens - Pneumonia is a common illness affecting millions of p...

Read More >

G6PD Deficiency

Why is a rapid G6PD test of interest? Glucose-6-phosphate dehydrogenase (G6PD) is a housekeeping enz...

Read More >

Oxford BioSystems

184B Park Drive Milton Park Abingdon Oxon OX14 4SE

Oxford Biosystems has pledged to be an Antibiotic Guardian

members of

BIVDA Member Logo IBMS Company Member